William B. Walkup & Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8K Buy
1,465
+240
+20% +$1.81K 0.01% 117
2025
Q4
$8.78K Sell
1,225
-240
-16% -$1.9K ﹤0.01% 137
2025
Q3
$15.6K Hold
1,465
0.01% 125
2025
Q2
$14.2K Hold
1,465
0.01% 125
2025
Q1
$21.8K Sell
1,465
-35
-2% -$538 0.01% 116
2024
Q4
$22.4K Hold
1,500
0.01% 116
2024
Q3
$28.7K Sell
1,500
-14
-0.9% -$290 0.02% 108
2024
Q2
$31.3K Buy
+1,514
New +$30.1K 0.02% 107

Other funds holding OGN

William B. Walkup & Associates's OGN Position: Q1 2026 in Review

William B. Walkup & Associates increased its Organon & Co (OGN) stake by 20% in Q1 2026, buying an estimated $1.81K and bringing the position to 1,465 shares worth $21.8K. The position accounts for 0.01% of the portfolio, ranked #117.

William B. Walkup & Associates first reported a position in OGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $31.3K in Q2 2024. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • William B. Walkup & Associates held 1,465 shares of Organon & Co worth $21.8K as of Q1 2026.
  • William B. Walkup & Associates bought 240 Organon & Co shares in Q1 2026, an estimated $1.81K.
  • Organon & Co made up 0.01% of William B. Walkup & Associates's portfolio in Q1 2026, its #117 holding.
  • William B. Walkup & Associates first reported a position in Organon & Co in Q2 2024 and has held it in 8 quarters since.
  • William B. Walkup & Associates's Organon & Co position peaked at $31.3K in Q2 2024.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on William B. Walkup & Associates's 13F filing for Q1 2026, filed 20 Apr 2026.